Medicus Pharma (MDCX) Income Statement: Revenue & Earnings

Medicus Pharma Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Medicus Pharma Ltd. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	3.53	0.19	0.65	1.18
Selling, General & Administrative	7.65	4.27	0.33	0.26
Operating Expenses	11.18	4.46	0.98	1.44
Operating Income	-11.18	-4.46	-0.98	-1.44
Other Income/Expense
Interest Income	0.10	0.00	0.00	0.00
Interest Expense	-0.08	-1.25	0.53	0.12
Other Income/Expense	0.03	0.67	0.39	0.08
Income
Income Before Tax	-11.16	-5.31	-1.69	-2.06
Income Tax Expense	0.00	0.00	0.00	0.00
Net Income	-11.16	-5.31	-1.69	-2.06
Net Income - Continuous Operations	-11.16	-5.31	-1.69	-2.06
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00
EBITDA	-11.08	-2.66	-1.17	-1.94
EBIT	-11.18	-4.46	-1.17	-1.94
Depreciation & Amortization	0.10	0.00	0.00	0.00
Earnings Per Share
Basic EPS	-1.00	-2.00	-1.00	-
Diluted EPS	-1.00	-2.00	-1.00	-
Basic Shares Outstanding	9.62	3.48	1.93	8.05
Diluted Shares Outstanding	9.62	3.48	8.05	8.05